ch.oddb.org
 
Apotheken | Hôpital | Interactions | LiMA | Médecin | Médicaments | Services | T. de l'Autorisation
Capvaxive, Injektionslösung in Fertigspritze - 
69781001 MSD Merck Sharp & Dohme AG
Capvaxive, Injektionslösung in Fertigspritze23.09.2025
  23.09.2025
Pneumokokken, gereinigtes Polysaccharid-Antigen, konjugiert (J07AL02) 
DDD-OMS22.09.2030
08.08. 
08.08. 
B  
Oui 
IPro 
63.84Oui
    
10%85.85
  
7680697810019Impfstoffe
  
Composition
polysaccharida streptococci pneumoniae typus 3 conjugata cum proteino corynebacteriae diphtheriae CRM 197 4 µg, polysaccharida streptococci pneumoniae typus 6A conjugata cum proteino corynebacteriae diphtheriae CRM 197 4 µg, polysaccharida streptococci pneumoniae typus 7F conjugata cum proteino corynebacteriae diphtheriae CRM 197 4 µg, polysaccharida streptococci pneumoniae typus 8 conjugata cum proteino corynebacteriae diphtheriae CRM 197 4 µg, polysaccharida streptococci pneumoniae typus 9N conjugata cum proteino corynebacteriae diphtheriae CRM 197 4 µg, polysaccharida streptococci pneumoniae typus 10A conjugata cum proteino corynebacteriae diphtheriae CRM 197 4 µg, polysaccharida streptococci pneumoniae typus 11A conjugata cum proteino corynebacteriae diphtheriae CRM 197 4 µg, polysaccharida streptococci pneumoniae typus 12F conjugata cum proteino corynebacteriae diphtheriae CRM 197 4 µg, polysaccharida streptococci pneumoniae typus 15A conjugata cum proteino corynebacteriae diphtheriae CRM 197 4 µg, polysaccharida streptococci pneumoniae typus 15B de-O-acetylatus conjugata cum proteino corynebacteriae diphtheriae CRM 197 4 µg, polysaccharida streptococci pneumoniae typus 16F conjugata cum proteino corynebacteriae diphtheriae CRM 197 4 µg, polysaccharida streptococci pneumoniae typus 17F conjugata cum proteino corynebacteriae diphtheriae CRM 197 4 µg, polysaccharida streptococci pneumoniae typus 19A conjugata cum proteino corynebacteriae diphtheriae CRM 197 4 µg, polysaccharida streptococci pneumoniae typus 20A conjugata cum proteino corynebacteriae diphtheriae CRM 197 4 µg, polysaccharida streptococci pneumoniae typus 22F conjugata cum proteino corynebacteriae diphtheriae CRM 197 4 µg, polysaccharida streptococci pneumoniae typus 23A conjugata cum proteino corynebacteriae diphtheriae CRM 197 4 µg, polysaccharida streptococci pneumoniae typus 23B conjugata cum proteino corynebacteriae diphtheriae CRM 197 4 µg, polysaccharida streptococci pneumoniae typus 24F conjugata cum proteino corynebacteriae diphtheriae CRM 197 4 µg, polysaccharida streptococci pneumoniae typus 31 conjugata cum proteino corynebacteriae diphtheriae CRM 197 4 µg, polysaccharida streptococci pneumoniae typus 33F conjugata cum proteino corynebacteriae diphtheriae CRM 197 4 µg, polysaccharida streptococci pneumoniae typus 35B conjugata cum proteino corynebacteriae diphtheriae CRM 197 4 µg, corresp. proteinum corynebacteriae diphtheriae CRM 197 65 µg, polysorbatum 20, histidinum, acidum hydrochloridum ad pH, natrii chloridum corresp. natrium 1.77 mg, aqua ad iniectabile q.s. ad solutionem pro 0.5 ml,
Packungsbestandteile
Solution injectable en seringue prête à l'emploi 
  
 
Principe actifConcentr.
Polysaccharida Streptococci Pneumoniae Typus 10a Conjugata cum Proteino Corynebacteriae Diphtheriae crm 1974µg / 0.5ml
Polysaccharida Streptococci Pneumoniae Typus 11a Conjugata cum Proteino Corynebacteriae Diphtheriae crm 1974µg / 0.5ml
Polysaccharida Streptococci Pneumoniae Typus 12f Conjugata cum Proteino Corynebacteriae Diphtheriae crm 1974µg / 0.5ml
Polysaccharida Streptococci Pneumoniae Typus 15a Conjugata cum Proteino Corynebacteriae Diphtheriae crm 1974µg / 0.5ml
Polysaccharida Streptococci Pneumoniae Typus 15b De-O-Acetylatus Conjugata cum Proteino Corynebacteriae Diphtheriae crm 1974µg / 0.5ml
Polysaccharida Streptococci Pneumoniae Typus 16f Conjugata cum Proteino Corynebacteriae Diphtheriae crm 1974µg / 0.5ml
Polysaccharida Streptococci Pneumoniae Typus 17f Conjugata cum Proteino Corynebacteriae Diphtheriae crm 1974µg / 0.5ml
Polysaccharida Streptococci Pneumoniae Typus 19a Conjugata cum Proteino Corynebacteriae Diphtheriae crm 1974µg / 0.5ml
Polysaccharida Streptococci Pneumoniae Typus 20a Conjugata cum Proteino Corynebacteriae Diphtheriae crm 1974µg / 0.5ml
Polysaccharida Streptococci Pneumoniae Typus 22f Conjugata cum Proteino Corynebacteriae Diphtheriae crm 1974µg / 0.5ml
Polysaccharida Streptococci Pneumoniae Typus 23a Conjugata cum Proteino Corynebacteriae Diphtheriae crm 1974µg / 0.5ml
Polysaccharida Streptococci Pneumoniae Typus 23b Conjugata cum Proteino Corynebacteriae Diphtheriae crm 1974µg / 0.5ml
Polysaccharida Streptococci Pneumoniae Typus 24f Conjugata cum Proteino Corynebacteriae Diphtheriae crm 1974µg / 0.5ml
Polysaccharida Streptococci Pneumoniae Typus 33f Conjugata cum Proteino Corynebacteriae Diphtheriae crm 1974µg / 0.5ml
Polysaccharida Streptococci Pneumoniae Typus 35b Conjugata cum Proteino Corynebacteriae Diphtheriae crm 1974µg / 0.5ml correspond Proteinum Corynebacteriae Diphtheriae crm 197 65µg / 0.5ml
Polysaccharida Streptococci Pneumoniae Typus 6A Conjugata cum Proteino Corynebacteriae Diphtheriae crm 1974µg / 0.5ml
Polysaccharida Streptococci Pneumoniae Typus 7F Conjugata cum Proteino Corynebacteriae Diphtheriae crm 1974µg / 0.5ml
Polysaccharida Streptococci Pneumoniae Typus 9N Conjugata cum Proteino Corynebacteriae Diphtheriae crm 1974µg / 0.5ml
BAG: Principe actifConcentr.
Vaccinum Pneumococcale Polysaccharidicum crm Conjugatum 21-Valens0.149 mg
 
Agents auxilliairesConcentr.
Acidum Hydrochloridum ad Ph 
Conjugata cum Proteino Corynebacteriae Diphtheriae crm 1974µg / 0.5ml
Histidine 
Sodium Chlorure 
Polysaccharida Streptococci Pneumoniae Typus31
Polysorbatum 20 
 
Source
Date de'limport en base : 09.01.2026 Enregistrement Swissmedic : Séquence : Nom du produit : Titulaire de l'Autorisation: : Groupe produit : Index Therapeuticus (BSV) : Code médicament : Date d'enregistrement : Valable jusqu'au: : Numéro d'emballage : Taille des présentations : Forme commerciale/Unité : Catégorie de livraison : P. Actifs : Composition :
 
2026 ©ywesee GmbH
Einstellungen | Aide | Identification | Contact | Home